VR
Vivek Rajgarhia
About Vivek Rajgarhia
Data last updated:
Vivek Rajgarhia is a Whole-Time Director at Finecure Pharmaceuticals Limited (since 2005), Director at Finebiotics Pharma Limited (since 2012) and Director at Global Medisciences Limited (since 2007), and holds 1 more current directorship. The companies operate in Pharma and Agriculture. The 4 current companies with reported revenue have a combined latest revenue of ₹228 Cr; the largest is Finecure Pharmaceuticals Limited at ₹202 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Finecure Pharmaceuticals Limited U24230GJ2005PLC045724 | Whole-Time Director | 18 Mar 2005 | 2005 | ₹202 Cr (FY 2025) | Active |
 Finebiotics Pharma Limited U24231GJ2004PLC044581 | Director | 16 Aug 2012 | 2004 | ₹26.36 Cr (FY 2025) | Active |
 Global Medisciences Limited U24239GJ2003PLC056518 | Director | 01 Feb 2007 | 2003 | ₹10.3 Lakh (FY 2025) | Active |
| Finecure Foundation U85300GJ2021NPL120309 | Director | 17 Feb 2021 | 2021 | ₹12,365 (FY 2025) | Active |
Board colleagues of Vivek Rajgarhia
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Rajgarhia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Rajgarhia
Vivek Rajgarhia currently holds 4 directorships: Finecure Pharmaceuticals Limited (Whole-Time Director, since 18 Mar 2005, revenue ₹202 Cr (FY 2025)); Finebiotics Pharma Limited (Director, since 16 Aug 2012, revenue ₹26.36 Cr (FY 2025)); Global Medisciences Limited (Director, since 01 Feb 2007, revenue ₹10.3 Lakh (FY 2025)); Finecure Foundation (Director, since 17 Feb 2021, revenue ₹12,365 (FY 2025)).
Vivek Rajgarhia was first appointed on 18 Mar 2005 as Whole-Time Director at Finecure Pharmaceuticals Limited. The most recent appointment on record is 17 Feb 2021 at Finecure Foundation.
The 4 current companies of Vivek Rajgarhia that report revenue have a combined latest revenue of ₹228 Cr: Finecure Pharmaceuticals Limited ₹202 Cr (FY 2025); Finebiotics Pharma Limited ₹26.36 Cr (FY 2025); Global Medisciences Limited ₹10.3 Lakh (FY 2025); Finecure Foundation ₹12,365 (FY 2025).
The current boards of Vivek Rajgarhia's companies include Anshu Krishnakumar Agrawal (Finecure Pharmaceuticals Limited), Ashish Subhash Chandra Sanghvi (Finecure Pharmaceuticals Limited), Mukesh Tarachand Agarwal (Finecure Pharmaceuticals Limited), Niraj Kumar Harodia (Finecure Pharmaceuticals Limited), Sonamben Vijaykumar Zatkiya (Finecure Pharmaceuticals Limited), Vikash Rajgarhia (Finecure Pharmaceuticals Limited), among others.